SM
IMUC
Sabby Management’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-139,912
| Closed | -$445K | – | 209 |
|
|
2017
Q1 | $445K | Sell |
139,912
-20,217
| -13% | -$64.3K | 0.02% | 86 |
|
|
2016
Q4 | $328K | Sell |
160,129
-6,245,101
| -98% | -$12.8M | 0.02% | 107 |
|
|
2016
Q3 | $756K | Buy |
6,405,230
+1,953,102
| +44% | +$231K | 0.03% | 85 |
|
|
2016
Q2 | $1.03M | Buy |
4,452,128
+40,757
| +0.9% | +$9.38K | 0.05% | 69 |
|
|
2016
Q1 | $1.28M | Sell |
4,411,371
-32,543
| -0.7% | -$9.44K | 0.06% | 73 |
|
|
2015
Q4 | $1.58M | Buy |
4,443,914
+274,671
| +7% | +$97.6K | 0.09% | 58 |
|
|
2015
Q3 | $1.75M | Sell |
4,169,243
-1,702,573
| -29% | -$715K | 0.07% | 75 |
|
|
2015
Q2 | $2.77M | Sell |
5,871,816
-17,205
| -0.3% | -$8.12K | 0.1% | 44 |
|
|
2015
Q1 | $2.86M | Buy |
+5,889,021
| New | +$2.86M | 0.12% | 37 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 195 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 196 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 178 |
|
|
2014
Q1 | – | Sell |
-25,000
| Closed | -$23K | – | 176 |
|
|
2013
Q4 | $23K | Buy |
+25,000
| New | +$23K | ﹤0.01% | 75 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 150 |
|